$PDSB
PDS Biotechnology Corp

2022 Q3 Form 10-Q Financial Statement

#000114036122028567 Filed on August 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.926M $3.331M $3.318M
YoY Change -10.63% 42.24% 102.31%
% of Gross Profit
Research & Development $4.353M $3.762M $5.161M
YoY Change 18.03% 36.08% 265.26%
% of Gross Profit
Depreciation & Amortization $37.41K $0.00 $90.00
YoY Change 2822.66% -100.0% -95.16%
% of Gross Profit
Operating Expenses $7.279M $7.093M $8.479M
YoY Change 4.55% 38.91% 178.07%
Operating Profit -$7.279M -$7.093M -$8.479M
YoY Change 4.55% 38.91% 178.07%
Interest Expense -$145.3K $74.55K $5.700K
YoY Change -10780.44% 12325.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$7.424M -$7.018M -$8.474M
YoY Change 6.66% 37.46% 177.82%
Income Tax $0.00 -$1.199M $0.00
% Of Pretax Income
Net Earnings -$7.424M -$5.819M -$8.474M
YoY Change 6.66% 888.1% 177.95%
Net Earnings / Revenue
Basic Earnings Per Share -$0.26 -$0.20 -$0.32
Diluted Earnings Per Share -$0.26 -$0.20 -$0.32
COMMON SHARES
Basic Shares Outstanding 28.46M 28.45M 26.16M
Diluted Shares Outstanding 28.46M 28.45M 26.16M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $71.64M $52.98M $58.88M
YoY Change 2.72% -29.12% 135.52%
Cash & Equivalents $71.60M $53.00M $58.88M
Short-Term Investments
Other Short-Term Assets $2.769M $2.758M $1.849M
YoY Change 73.4% 26.21% -15.94%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $74.41M $55.74M $60.73M
YoY Change 4.3% -27.55% 122.81%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $308.3K
YoY Change -100.0% -100.0% 8505.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $475.4K $258.2K $308.3K
YoY Change 16.75% -43.42% -38.92%
TOTAL ASSETS
Total Short-Term Assets $74.41M $55.74M $60.73M
Total Long-Term Assets $475.4K $258.2K $308.3K
Total Assets $74.89M $56.00M $61.04M
YoY Change 4.37% -27.64% 119.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.037M $1.878M $2.746M
YoY Change 40.94% -20.94% 188.84%
Accrued Expenses $2.429M $2.303M $2.273M
YoY Change 26.23% 56.68% 22.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $61.27K
YoY Change
Total Short-Term Liabilities $4.841M $4.516M $5.018M
YoY Change 35.34% 12.82% 71.34%
LONG-TERM LIABILITIES
Long-Term Debt $22.99M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $59.65K $147.0K
YoY Change -100.0% -84.91% -70.6%
Total Long-Term Liabilities $22.99M $59.65K $147.0K
YoY Change 7221.1% -84.91% -70.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.841M $4.516M $5.018M
Total Long-Term Liabilities $22.99M $59.65K $147.0K
Total Liabilities $27.83M $4.576M $5.165M
YoY Change 615.16% 4.03% 52.49%
SHAREHOLDERS EQUITY
Retained Earnings -$82.42M -$75.00M
YoY Change
Common Stock $9.391K $9.391K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.06M $51.43M $55.87M
YoY Change
Total Liabilities & Shareholders Equity $74.89M $56.00M $61.04M
YoY Change 4.37% -27.64% 119.87%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$7.424M -$5.819M -$8.474M
YoY Change 6.66% 888.1% 177.95%
Depreciation, Depletion And Amortization $37.41K $0.00 $90.00
YoY Change 2822.66% -100.0% -95.16%
Cash From Operating Activities -$5.893M -$5.919M -$6.369M
YoY Change 14.9% -726.98% 67.51%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.55M 22.43K 7.490K
YoY Change 19777.48% -99.95%
NET CHANGE
Cash From Operating Activities -5.893M -5.919M -6.369M
Cash From Investing Activities
Cash From Financing Activities 24.55M 22.43K 7.490K
Net Change In Cash 18.66M -5.896M -6.362M
YoY Change -472.77% -111.86% 67.31%
FREE CASH FLOW
Cash From Operating Activities -$5.893M -$5.919M -$6.369M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001472091
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52984672
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74749200
CY2022Q2 pdsb Shelf Securities Available For Sale
ShelfSecuritiesAvailableForSale
29300000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53000000.0
CY2022Q2 pdsb Common Stock Purchase Agreement Cumulative Shares Sold
CommonStockPurchaseAgreementCumulativeSharesSold
0
CY2020Q3 pdsb Shelf Registration Statement Available For Future Sale
ShelfRegistrationStatementAvailableForFutureSale
100000000
CY2021Q2 pdsb Proceeds From Sale Of Unused Net Operating Loss Carryforwards
ProceedsFromSaleOfUnusedNetOperatingLossCarryforwards
4500000
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6088235
CY2021Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
8.50
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
51700000
CY2021Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
48500000
CY2022Q2 pdsb Proceeds From Sale Of Unused Net Operating Loss Carryforwards
ProceedsFromSaleOfUnusedNetOperatingLossCarryforwards
1200000
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
52984672
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
65242622
CY2022Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
11200
CY2022Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P40M
CY2022Q2 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P14M
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
700000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
700000
CY2020Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0915
us-gaap Operating Lease Payments
OperatingLeasePayments
116783
us-gaap Operating Lease Payments
OperatingLeasePayments
84115
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
0
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
178206
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
239470
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
0
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0
CY2022Q2 pdsb Lessee Operating Lease Liability To Be Paid Year Four And Thereafter
LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter
0
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
417676
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
23014
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
394662
CY2022Q2 pdsb Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
278228
CY2021Q4 pdsb Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
227400
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
765657
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
485400
CY2022Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1259036
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1458310
CY2022Q2 us-gaap Accrued Rent Current
AccruedRentCurrent
0
CY2021Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
16594
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2302921
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2187704
CY2022Q2 pdsb Number Of Equity Based Compensation Plans
NumberOfEquityBasedCompensationPlans
3
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q2 pdsb Liability For Uncertain Tax Positions
LiabilityForUncertainTaxPositions
0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1348601
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
441598
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2477574
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
699219
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0005
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0063
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9945
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0059
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0260
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0079
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0162
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0072
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y7D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M17D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M4D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M10D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.01
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.28
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.39
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
55500
us-gaap Operating Lease Cost
OperatingLeaseCost
111000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
42477
us-gaap Operating Lease Cost
OperatingLeaseCost
78493
CY2022Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
38761
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
87718
CY2021Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
28352
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
45411

Files In Submission

Name View Source Status
0001140361-22-028567-index-headers.html Edgar Link pending
0001140361-22-028567-index.html Edgar Link pending
0001140361-22-028567.txt Edgar Link pending
0001140361-22-028567-xbrl.zip Edgar Link pending
brhc10040092_10q.htm Edgar Link pending
brhc10040092_ex10-1.htm Edgar Link pending
brhc10040092_ex10-2.htm Edgar Link pending
brhc10040092_ex10-3.htm Edgar Link pending
brhc10040092_ex31-1.htm Edgar Link pending
brhc10040092_ex31-2.htm Edgar Link pending
brhc10040092_ex32-1.htm Edgar Link pending
brhc10040092_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
brhc10040092_10q_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
image001.jpg Edgar Link pending
image002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
pdsb-20220630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pdsb-20220630_cal.xml Edgar Link unprocessable
pdsb-20220630_pre.xml Edgar Link unprocessable
pdsb-20220630_def.xml Edgar Link unprocessable
pdsb-20220630_lab.xml Edgar Link unprocessable